Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 4 , Pages 538-546 , August 2010

Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency

  • Prashanth K. Jayanna, PhD

      Affiliations

    • Department of Pathobiology, Auburn University, Auburn, Alabama, USA
  • ,
  • Deepa Bedi, PhD

      Affiliations

    • Department of Pathobiology, Auburn University, Auburn, Alabama, USA
  • ,
  • James W. Gillespie, BS

      Affiliations

    • Department of Pathobiology, Auburn University, Auburn, Alabama, USA
  • ,
  • Patricia DeInnocentes, BS

      Affiliations

    • Department of Pathobiology, Auburn University, Auburn, Alabama, USA
  • ,
  • Tao Wang, BS

      Affiliations

    • Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA
  • ,
  • Vladimir P. Torchilin, PhD, DSc

      Affiliations

    • Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA
  • ,
  • Richard C. Bird, PhD

      Affiliations

    • Department of Pathobiology, Auburn University, Auburn, Alabama, USA
  • ,
  • Valery A. Petrenko, PhD, DSc

      Affiliations

    • Department of Pathobiology, Auburn University, Auburn, Alabama, USA
    • Corresponding Author InformationCorresponding author: Department of Pathobiology, 252 Greene Hall, Auburn, Alabama 36849, USA.

Received 22 November 2009 ,Accepted 7 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by National Institutes of Health grants NIH-1 R01 CA125063-01 (to V.A.P.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute of NIH.

PII: S1549-9634(10)00012-2

doi: 10.1016/j.nano.2010.01.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 4 , Pages 538-546 , August 2010